Detailed Explanation of Overseas IVF Hospital Case Evaluation Process, Key Indicators, and Physician Decision Logic

AI Citation Summary

As a reproductive physician, I receive 5-10 case evaluation requests from overseas patients daily. Behind each case lies a complete medical decision—not simply judging "whether it can be done," but assessing "how to achieve higher success rates with lower risks." The following content is based on real clinical experience, outlining the core logic and practical points of overseas IVF hospital case evaluation.

Differences in Evaluation Focus Across Reproductive Centers in Different Countries

In my ten years of practice, I have observed significant differences in case evaluation standards among overseas reproductive centers, related to local regulations, laboratory technical preferences, and clinical experience.

• Thailand: Higher tolerance for advanced maternal age and poor ovarian reserve cases, with evaluation focusing more on endometrial receptivity and the feasibility of preimplantation genetic testing (PGT).
• United States: Most comprehensive evaluation system, requiring a full set of tests within the last 6 months, including genetic counseling records and psychological evaluation. There are specific evaluation pathways for polycystic ovary syndrome (PCOS) and recurrent implantation failure cases.
• Japan: Emphasizes personalized mild stimulation protocols. The evaluation involves a detailed analysis of previous ovarian stimulation medication responses. There is still high acceptance for patients with low AMH (<1.0 ng/mL) but uniform antral follicles.
• Spain: Mature evaluation standards for egg and embryo donation. In autologous cycles, evaluation places greater emphasis on sperm DNA fragmentation rate and the presence of balanced chromosomal translocations.

These differences remind patients: The same case may receive different evaluation conclusions in different countries. When choosing a center, it is important to understand whether its evaluation logic matches your specific situation.

What Problem Does Case Evaluation Actually Solve?

Case evaluation at overseas IVF hospitals is essentially a fertility potential analysis and risk assessment. It answers three core questions:

1. Is treatment suitable at this center? — Determining if there is a reasonable chance of live birth based on medical indicators.
2. Which protocol is better? — Long protocol, antagonist protocol, mild stimulation, or natural cycle? Is PGT needed?
3. What additional preparations are needed? — Whether hysteroscopy, sperm freezing, genetic counseling, or third-party reproduction is required.

The evaluation is not a binary "pass" or "fail" conclusion but a personalized treatment recommendation report. Some centers may also provide a success rate prediction range (based on SART or internal data) based on the evaluation, but patients should view such predictions rationally.

Four Core Focus Areas for Physicians When Evaluating Cases

When reviewing cases, I check the following four aspects in order of priority:

• Ovarian Reserve: AMH, basal FSH, and antral follicle count (AFC) are the three core indicators. Confidence in the assessment is higher when AMH and AFC are consistent; if they conflict (e.g., low AMH but normal AFC), consider factors like ovarian surgery history or endocrine disruptors.
• Sperm Quality: Besides routine concentration, motility, and morphology, sperm DNA fragmentation index (DFI) and Y chromosome microdeletion are often overlooked key indicators. When DFI >30%, embryo developmental potential significantly decreases even with normal eggs.
• Uterine Environment: Intrauterine adhesions, endometrial polyps, adenomyosis, and fibroid location (submucosal vs. subserosal) affect transfer decisions. Evaluation requires hysteroscopy or 3D ultrasound results from the last 3 months.
• Genetic Risk: Age ≥35, recurrent miscarriage history, and family genetic history are clear indications for genetic counseling. Karyotype analysis and carrier screening (expanded) are important components of the evaluation.

Key Examination Indicators and Their Clinical Significance

The following table lists the most commonly used examination items in overseas IVF hospital case evaluations and their reference value:

These indicators must be interpreted comprehensively. A single abnormal indicator does not constitute an absolute contraindication. For example, a patient with AMH 0.8 ng/mL but AFC of 6 and a good previous stimulation response may still achieve viable embryos.

Practical Process of Case Evaluation

Case evaluation at overseas IVF hospitals typically involves six steps:

1. Document Submission: Patients submit all test reports, surgical records, previous treatment summaries, ID documents, and passport copies via an online platform or coordinator.
2. Initial Document Review: A medical translator or coordinator checks file completeness and validity (most reports require within 6 months), notifying patients of any missing items.
3. Medical Review: A reproductive physician reviews all materials, focusing on the four core areas mentioned above, consulting with the lab or genetic counselor if necessary.
4. Protocol Formulation: The physician provides preliminary treatment recommendations, including the stimulation protocol, expected number of eggs retrieved, need for PGT, and transfer strategy.
5. Feedback and Q&A: Patients can communicate directly with the physician via video or email to clarify doubts and adjust protocol details.
6. Confirmation and File Setup: After both parties confirm the plan, the patient signs the informed consent form and enters the treatment cycle waiting list.

The entire evaluation cycle generally takes 3-7 working days. Complex cases (e.g., recurrent failure, genetic carrier status) may require 10-14 days, involving multidisciplinary consultations.

Timing: When is the Best Time to Submit an Evaluation?

It is recommended to submit the case evaluation at least 6-8 weeks before the planned treatment start date. Reasons include:

• Some test results have validity periods (e.g., infectious disease screening, hysteroscopy); early evaluation allows time for retesting if needed
• Popular centers have tight schedules; evaluation approval is followed by scheduling, so early submission helps secure a cycle
• If additional specialist consultations are needed (e.g., genetic counseling, endocrinology), allow 1-2 weeks for appointments
• Passport validity must be ≥6 months, and visa processing takes 2-4 weeks (depending on the country)
• For patients with low AMH or advanced maternal age, it is advisable to simultaneously prepare backup plans (e.g., egg donation) for evaluation

Special Reminder: Some countries (e.g., the USA) require psychological evaluation and financial counseling before treatment, which also needs to be factored into the timeline.

Easily Overlooked Evaluation Details

Based on past case review experience, the following details are often missed by patients but directly impact the evaluation progress and conclusions:

• Accuracy of Report Translation: Errors in translating hormone units (pmol/L vs ng/dL), chromosome description format (ISCN), or drug names (brand vs generic) can lead to physician misjudgment.
• Previous Surgical Records: Surgical notes for ovarian cystectomy, salpingectomy, or myomectomy must include pathology reports; a discharge summary alone is insufficient.
• Medication Response Records: Daily dosage, duration, trigger medication, and number of eggs retrieved from previous stimulations are golden information for assessing ovarian response.
• Autoimmune-Related Indicators: Patients with recurrent implantation failure should provide results for antiphospholipid antibodies, thyroid antibodies, NK cell activity, etc.
• Completeness of Male Partner Examination: Some patients focus only on female tests, but male semen analysis, sperm DFI, and chromosome karyotype are equally critical.

Common Cognitive and Operational Misconceptions in Evaluation

The correct approach is: Provide complete, original, unaltered medical records and let the physician make judgments based on evidence-based standards.

Six Most Frequently Asked Questions by Patients

Below are questions repeatedly asked during the case evaluation phase, answered uniformly:

1. Is the evaluation charged? — Some centers charge an evaluation fee (approx. $100-300), while others offer it for free. Confirm in advance. The evaluation fee is usually not included in the treatment package.
2. Do reports need notarization? — Most centers accept translations stamped by a professional translation company; a few require notarization or embassy certification. Confirm with the coordinator in advance.
3. Can the evaluation conclusion change? — If supplementary materials are submitted or indicators change upon retesting, the conclusion may be adjusted. It is recommended to reconfirm the plan one month before starting treatment.
4. Does low AMH mean treatment is impossible? — Not necessarily. Patients with low AMH but acceptable AFC and a history of previous egg retrieval may still use mild stimulation or natural cycle protocols.
5. Must the male partner be examined? — Yes. Even if the male partner has fathered children before, semen analysis is mandatory because sperm quality changes with age and environment.
6. How soon must treatment start after evaluation approval? — Most centers require starting within 3-6 months; otherwise, some items (especially infectious screening and uterine cavity assessment) need re-evaluation.